Victorian IVF reforms introduced

7 July 2020 Position Statement: Genea welcomes the news that those struggling to conceive in Victoria will no longer need to pass police and child welfare checks before being approved to commence fertility treatment. The ART Amendment Bill has now received the Royal Assent, reforms will be effective as of 8 July 2020.

“Victoria is the only jurisdiction in the world that requires couples and individuals wanting IVF and other assisted reproductive technology treatments to undergo checks,” said General Manager of Fertility Kathleen Waite.

She added, “it adds an unnecessary step to the IVF journey, it is also discriminatory and not something endured by those who conceive naturally. Genea is pleased the government has listened to calls to remove the checks, anything we can do to make the process less stressful without compromising care and success is welcome news.”
Download a PDF of the press release
Meline Walton
Media & Communications Manager
M: +61 452 433 369

About Genea
Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 33 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. In July 2018, Genea was the highest ranked healthcare provider named on Australian Financial Review’s Top 100 Most Innovative Companies List, ranked number 18.

Genea’s sister company, Genea Biomedx creates and manufactures practical, accessible and precise fertility technologies that help standardise and automate fertility treatment. Its unique relationship with Genea Fertility means that Genea Biomedx is a manufacturer that truly understands the customers’ perspective. As a result, Genea Biomedx has developed the world’s first automated vitrification instrument and has created a world leading benchtop incubator with timelapse functionality.

About Gavi, Geri, Gems and Gidget
  • Gavi – the world’s first automated vitrification instrument; Vitrification is a process used in IVF to preserve human egg cells (ooc ytes) or embryos by cooling them to deep sub-zero degrees. Approaching the process in an innovative way, Gavi uses an automated, standardized protocol aiming to provide consistent results in blastocyst vitrification.
  • Geri - a benchtop incubator with individually controlled incubation chambers per patient to minimize disruptive events to the early-stage embryo. It also incorporates a camera for continuous monitoring of embryos as they develop.
  • Gems - the latest generation of Genea’s culture media for embryo cultivation.
  • Gidget - an innovative witnessing and tracking system that provides electronic witnessing, lab workflow management and support for traceability and audit reporting.